CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 137 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $11,770,000 | -4.1% | 104,066 | -15.1% | 2.03% | +13.8% |
| Q1 2017 | $12,268,000 | -12.3% | 122,523 | -5.8% | 1.78% | -14.3% |
| Q4 2016 | $13,991,000 | +56.1% | 130,130 | +80.7% | 2.08% | +61.5% |
| Q3 2016 | $8,964,000 | +92.9% | 72,013 | +64.7% | 1.29% | +85.4% |
| Q2 2016 | $4,648,000 | +13.9% | 43,718 | +22.7% | 0.69% | +20.5% |
| Q1 2016 | $4,080,000 | -12.3% | 35,642 | +9.1% | 0.58% | -11.9% |
| Q4 2015 | $4,653,000 | – | 32,658 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WARBURG PINCUS LLC | 8,344,200 | $960,918,000 | 7.67% |
| RUDMAN ERROL M | 130,201 | $14,994,000 | 5.06% |
| Ativo Capital Management LLC | 59,101 | $7,258,000 | 2.56% |
| Kylin Management | 188,226 | $21,676,000 | 2.36% |
| Monashee Investment Management LLC | 40,000 | $4,606,000 | 2.17% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 62,866 | $7,240,000 | 1.91% |
| Cormorant Asset Management, LP | 111,500 | $12,840,000 | 1.71% |
| OBERWEIS ASSET MANAGEMENT INC/ | 53,500 | $6,161,000 | 1.63% |
| Perceptive Advisors | 147,604 | $16,998,000 | 1.02% |
| Granite Point Capital Management, L.P. | 29,160 | $3,358,000 | 0.98% |